Skip to Content

RE 19 (Atenolol 25 mg)

Pill with imprint RE 19 is White, Round and has been identified as Atenolol 25 mg. It is supplied by Ranbaxy Pharmaceuticals Inc..

Atenolol is used in the treatment of anxiety; high blood pressure; alcohol withdrawal; migraine prevention; angina (and more), and belongs to the drug class cardioselective beta blockers. There is positive evidence of human fetal risk during pregnancy. Atenolol 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for RE 19

Atenolol

Imprint:
RE 19
Strength:
25 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Cardioselective beta blockers
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Ranbaxy Pharmaceuticals Inc.
Inactive Ingredients:
magnesium carbonate
magnesium stearate
silicon dioxide colloidal
sodium lauryl sulfate
sodium starch glycolate type A potato
corn starch
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
53002-1108 Pharmedix (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide